Santen Pharmaceutical Co., Ltd. (SNPHY) Financials

SNPHY Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 2.7 billion 798.6 million
Dec. 31, 2025 2.6 billion 758.4 million
Sept. 30, 2025 2.6 billion 780.6 million
June 30, 2025 2.8 billion 889.4 million

SNPHY Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 123.5 million ?
Dec. 31, 2025 48.8 million ?
Sept. 30, 2025 30.0 million ?
June 30, 2025 282205 ?

SNPHY Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 99.1 million
Dec. 31, 2025 51.2 million
Sept. 30, 2025 55.4 million
June 30, 2025 40.9 million

SNPHY Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 508.5 million - -
Dec. 31, 2025 393.1 million 230.9 million -
Sept. 30, 2025 446.5 million 244.6 million -
June 30, 2025 588.1 million - -

SNPHY Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 ?
Dec. 31, 2025 2.1 million
Sept. 30, 2025 2.3 million
June 30, 2025 2.4 million

SNPHY Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 11.7 million 49.8 million 158.0 million -
Dec. 31, 2025 10.2 million 39.0 million 144.7 million -
Sept. 30, 2025 10.6 million 42.4 million 146.5 million -
June 30, 2025 89320 43.2 million 147.4 million -

SNPHY Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 515.5 million 198.8 million
Dec. 31, 2025 473.6 million 223.2 million
Sept. 30, 2025 475.3 million 215.4 million
June 30, 2025 478.0 million 219.9 million

SNPHY

Price: $11.61

52 week price:
9.22
12.68

Dividend Yield: 2.14%

Earnings Per Share: 0.72 USD

P/E Ratio: 16.53

Exchange: PNK

Sector: Healthcare

Industry: Drug Manufacturers - General

Market Capitalization: 3.8 billion

Links: